Skip to content
BidBenchmark

Contract award

EXELAN PHARMACEUTICALS INC

NEW AWARD FOR DICLOFENAC SODIUM 1% TOPICAL GEL WITH EXELAN PHARMACEUTICALS, INC. ORDERING PERIOD IS SEPTEMBER 3, 2025 TO SEPTEMBER 2, 2026 WITH FOUR ONE-YEAR OPTIONS.
PIID
36E79725D0047
Award key
CONT_IDV_36E79725D0047_3600
Recipient UEI
FYZXNHSQTMG8
Source as of
Current award value
3
Obligated to date
$02
Potential with options
$63,068,8323
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Set-aside
No set-aside used
Pricing
Firm Fixed Price
Competition
Full and Open Competition7 offers received
Period of performance
Sep 3, 2025Sep 2, 2027
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Jul 2, 2025Initial award$0.00
P00001Mar 17, 2026Y$0.00
P00002Aug 20, 2026G$0.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
contractor_idUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
current_award_valueUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
naics_codeUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
potential_award_valueUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
psc_codeUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9
total_obligatedUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.2d218666386c9

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 3 transaction records parsed from USAspending.gov, retrieved Aug 22, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36E79725D0047 — EXELAN PHARMACEUTICALS INC · BidBenchmark